WHO discontinues hydroxychloroquine trial for COVID-19 treatment

  • 4 years ago
The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir in hospitalised patients with Covid-19 after they failed to reduce mortality.

Recommended